Temperature-Tunable Iron Oxide Nanoparticles for Remote-Controlled Drug Release
- 328 Downloads
Herein, we report the successful development of a novel nanosystem capable of an efficient delivery and temperature-triggered drug release specifically aimed at cancer. The water-soluble 130.1 ± 0.2 nm iron oxide nanoparticles (IONPs) were obtained via synthesis of a monodispersed iron oxide core stabilized with tetramethylammonium hydroxide pentahydrate (TMAOH), followed by coating with the thermoresponsive copolymer poly-(NIPAM-stat-AAm)-block-PEI (PNAP). The PNAP layer on the surface of the IONP undergoes reversible temperature-dependent structural changes from a swollen to a collapsed state resulting in the controlled release of anticancer drugs loaded in the delivery vehicle. We demonstrated that the phase transition temperature of the prepared copolymer can be precisely tuned to the desired value in the range of 36°C–44°C by changing the monomers ratio during the preparation of the nanoparticles. Evidence of modification of the IONPs with the thermoresponsive copolymer is proven by ATR-FTIR and a quantitative analysis of the polymeric and iron oxide content obtained by thermogravimetric analysis. When loaded with doxorubicin (DOX), the IONPs-PNAP revealed a triggered drug release at a temperature that is a few degrees higher than the phase transition temperature of a copolymer. Furthermore, an in vitro study demonstrated an efficient internalization of the nanoparticles into the cancer cells and showed that the drug-free IONPs-PNAP were nontoxic toward the cells. In contrast, sufficient therapeutic effect was observed for the DOX-loaded nanosystem as a function of temperature. Thus, the developed temperature-tunable IONPs-based delivery system showed high potential for remotely triggered drug delivery and the eradication of cancer cells.
KEY WORDSdrug delivery IONPs remote-triggered drug release thermoresponsive copolymer tunable LCST
This work was supported in part by the funding provided by the Medical Research Foundation of Oregon, PhRMA Foundation and the College of Pharmacy, Oregon State University. We thank Teresa Sawyer (Electron Microscopy Facility, OSU) for TEM analysis and Dr. Christine Pastorek (Department of Chemistry, OSU) for access to the FTIR-ATR and TGA instruments.
- 1.Lopes J, Santos G, Barata P, Oliveira R, Lopes CM. Physical and chemical stimuliresponsive drug delivery systems: targeted delivery and main routes of administration. Curr Pharm Des. 2013;Epub ahead of print.Google Scholar
- 14.Hoogenboom R, Thijs HML, Jochems MJHC, Lankvelt BM, Fijten MWM, Schubert US. Tuning the LCST of poly(2-oxazoline)s by varying composition and molecular weight: alternatives to poly(N-isopropylacrylamide). Chem Comm. 2008;5758–60.Google Scholar
- 22.Talelli M, Rijcken CJF, Lammers T, Seevinck PR, Storm G, van Nostrum CF, et al. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir. 2009;25:2060–7.PubMedCrossRefGoogle Scholar